Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Oct 20:7:481-6.
doi: 10.2147/DMSO.S50777. eCollection 2014.

Testosterone levels and type 2 diabetes in men: current knowledge and clinical implications

Anne M Beatrice  1 , Deep Dutta  1 , Manoj Kumar  1 , Shivaprasad Kumbenahalli Siddegowda  1 , Ankur Sinha  1 , Sayantan Ray  1 , Subhankar Chowdhury  1
Affiliations
Review

Testosterone levels and type 2 diabetes in men: current knowledge and clinical implications

Anne M Beatrice et al. Diabetes Metab Syndr Obes. .

Abstract

The relationship between testosterone and diabetes is an important issue, given the fact that diabetes is becoming a fast-growing epidemic, the morbidity associated with which is more disabling than the disease itself. Various studies have demonstrated the increasing prevalence of hypogonadism in diabetic subjects, but whether this is a cause or effect is still an area of active research. The past couple of decades have witnessed an increasing rate of testosterone prescriptions, even though the relationship between testosterone therapy and cardiovascular effects is still not conclusive. The studies done in this regard have shown conflicting results, and there is still a dearth of long-term, follow-up studies in this field. This paper reviews in brief the postulated mechanisms, observational studies, and interventional data regarding the adverse effects of testosterone therapy in type 2 diabetes mellitus, stressing the cardiovascular risks.

Keywords: cardiovascular events; hypogonadism; quality of life; testosterone; type 2 diabetes.

PubMed Disclaimer

References

    1. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31–40. - PubMed
    1. Ferrannini E, Vichi S, Beck-Nielson H, Laakso M, Paolisso G, Smith U. Insulin action and age. Diabetes. 1996;54:947–956. - PubMed
    1. Haring R, Baumeister SE, Völzke H, et al. Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia. Eur J Cardiovasc Prev Rehabil. 2011;18:86–96. - PubMed
    1. Haring R, Völzke H, Felix SB, et al. Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania. Diabetes. 2009;58:2027–2031. - PMC - PubMed
    1. Schipf S, Haring R, Friedrich N, et al. Low total testosterone is associated with increased risk of incident type 2 diabetes mellitus in men: results from the Study of Health in Pomerania (SHIP) Aging Male. 2011;14:168–175. - PubMed

LinkOut - more resources